Mei Lan Thailand Co., Ltd. – FDA Warning Letter, Sep 22, 2023
The FDA issued a Warning Letter to Mei Lan (Thailand) Co., Ltd. (FEI 3012190301), an API manufacturer of crude (b)(4), located in Samut Sakhon, Thailand. The letter, dated January 22, 2024, stems from the firm's failure to permit a planned FDA inspection scheduled for September 18-22, 2023.
The FDA attempted to notify the firm of the inspection multiple times via email on May 23, June 6, June 21, and August 29, 2023, and also attempted to contact their U.S. Agent on August 25, 2023. A follow-up written request was sent via UPS and delivered on August 29, 2023. All attempts to communicate and schedule the inspection went unanswered.
This refusal to permit inspection constitutes a violation of section 501(j) of the FD&C Act, 21 U.S.C. 351(j), rendering the firm's drugs adulterated. As a result, the FDA placed Mei Lan (Thailand) Co., Ltd. on Import Alert 55-03 on January 18, 2024. The FDA will withhold approval of new applications or supplements listing the firm as a drug manufacturer until
ID · 285082a6-59ac-477c-af1a-9c1c1584a67f
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.